Abstract

<p>(a) The relationship between the factor XIII activity levels and plasma concentrations was assessed according to Pearson's correlation coefficient. (r = 0.449, <i>P</i> = 0.019). (b) Comparison of the plasma factor XIII concentrations between the RA patients treated with TNFi and those treated with tocilizumab. * Student's <i>t</i>-test (<i>P</i><0.05). TNFi, tumor necrosis factor inhibitors; TCZ, tocilizumab.</p

    Similar works

    Full text

    thumbnail-image

    Available Versions